CXCR4 and osteosarcoma: Previous preclinical and clinical studies have indicated the CXCR4, survivin and MMP9 were associated with the clinical outcome of osteosarcoma.7 Cisplatin is one of the effective chemotherapy in treatment of osteosarcoma, while NER pathway plays an important role on removing of DNA adducts induced by platinum compounds.